[Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D006801:Humans; D009643:Norfloxacin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015366:Pefloxacin
D000890:Anti-Infective Agents; D015366:Pefloxacin; D009643:Norfloxacin
Antibiothérapie de première intention au cours des bronchopneumopathies bactériennes graves. Etude randomisée d'une nouvelle quinolone: pefloxacine.